share_log

藥明巨諾-B：截至二零二四年三月三十一日止月份之股份發行人的證券變動月報表

JW THERAP-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2024

香港交易所 ·  Apr 5 04:32
Summary by Moomoo AI
药明巨诺-B（JW Therapeutics）於2024年4月5日向香港交易及結算所有限公司提交了最新的證券變動月報表，報告截至2024年3月31日的公司股份變動情況。報告顯示，公司的法定/註冊股本結存維持在5,000,000,000股，每股面值0.00001美元，總股本為50,000美元，本月無增減變動。在股份期權方面，根據2019年9月4日採納的首次公開發售前激勵計劃，本月內有176,000股股份期權被行使，而根據2020年10月14日採納的首次公開發售後激勵計劃，有909股股份期權失效。總計，公司本月普通股增加176,000股。公司確認，所有新發行的股份均已獲得董事會批准，並符合香港聯合交易所有限公司證券上市規則的相關要求。
药明巨诺-B（JW Therapeutics）於2024年4月5日向香港交易及結算所有限公司提交了最新的證券變動月報表，報告截至2024年3月31日的公司股份變動情況。報告顯示，公司的法定/註冊股本結存維持在5,000,000,000股，每股面值0.00001美元，總股本為50,000美元，本月無增減變動。在股份期權方面，根據2019年9月4日採納的首次公開發售前激勵計劃，本月內有176,000股股份期權被行使，而根據2020年10月14日採納的首次公開發售後激勵計劃，有909股股份期權失效。總計，公司本月普通股增加176,000股。公司確認，所有新發行的股份均已獲得董事會批准，並符合香港聯合交易所有限公司證券上市規則的相關要求。
JW Therapeutics filed its latest Securities Changes Month Report with Hong Kong Trading and Settlement Limited on April 5, 2024, reporting the changes in the company's shares for the year ended March 31, 2024. The report showed that the company's regulated/registered share capital was maintained at 5,000,000,000 shares with a face value of $0.00001 per share and a total share capital of $50,000, unchanged this month. In terms of stock options, under the Initial Public Offering Incentive Plan adopted on September 4, 2019, 176,000 share options were exercised this month, and 909 share options expired under the Initial Public Offering Incentive Plan adopted on October 14, 2020. Overall, the company's common stock increased by 176,000 shares this month. The Company confirms that all newly issued shares have been approved by the Board of Directors and comply with the relevant requirements of the Securities Listing Rules of the Hong Kong Stock Exchange Limited.
JW Therapeutics filed its latest Securities Changes Month Report with Hong Kong Trading and Settlement Limited on April 5, 2024, reporting the changes in the company's shares for the year ended March 31, 2024. The report showed that the company's regulated/registered share capital was maintained at 5,000,000,000 shares with a face value of $0.00001 per share and a total share capital of $50,000, unchanged this month. In terms of stock options, under the Initial Public Offering Incentive Plan adopted on September 4, 2019, 176,000 share options were exercised this month, and 909 share options expired under the Initial Public Offering Incentive Plan adopted on October 14, 2020. Overall, the company's common stock increased by 176,000 shares this month. The Company confirms that all newly issued shares have been approved by the Board of Directors and comply with the relevant requirements of the Securities Listing Rules of the Hong Kong Stock Exchange Limited.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more